SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-028901
Filing Date
2021-05-19
Accepted
2021-05-19 17:29:57
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 srne-s3.htm S-3 390753
2 EX-5.1 srne-ex51_6.htm EX-5.1 23646
3 EX-23.1 srne-ex231_21.htm EX-23.1 2686
4 EX-23.2 srne-ex232_22.htm EX-23.2 2566
5 GRAPHIC gn2ic2yhjwiw000002.jpg GRAPHIC 3210
6 GRAPHIC gisfesvrczx3000001.jpg GRAPHIC 11200
7 GRAPHIC gisfesvrczx3000002.jpg GRAPHIC 17892
8 GRAPHIC gn2ic2yhjwiw000001.jpg GRAPHIC 3210
  Complete submission text file 0001564590-21-028901.txt   470236
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256304 | Film No.: 21941409
SIC: 2836 Biological Products, (No Diagnostic Substances)